Scent of 'germ' warfare raises fear in the MidEast.
More than 167 nations have signed the United Nations Biological Weapons Convention. Syria is a signatory but has not ratified the treaty. Iran, also a signatory, has ratified it, but is pursuing development of microbial agents with the aid of Russian and North Korean scientists who may be graduates of the Soviet-era Biopreparat program that created some of these dangerous biological agents.
Among the more than 16 biological agents that Iran reportedly is developing are anthrax, Ebola, encephalitis, biological toxins, severe acute respiratory syndrome (SARS), cholera, smallpox and plague.
Worse yet, Iran, with North Korea's help, has genetically altered the smallpox virus in ways that may make current vaccinations ineffective.
The Islamists ruling Iran may think their planned microbial attacks cannot be traced to them. Biological weapons pose a risk that other weapon classes (nuclear, radiological and chemical) do not. They are living organisms, some of which are highly infectious and transmissible, depending on the strain. Some have lengthy incubation periods that make early detection exceptionally difficult.
Genetically modified, weaponized biological agents would pose threats for which there are no known medical countermeasures. Biological weapons are silent until they explode in epidemics or pandemics. Calculating kill ratios and controlling strikes as with chemical weapons and nuclear weapons are nearly impossible with biological weapons.
Intelligence analyst Andrew O'Neil said in a 2003 article in the Australian Journal of International Affairs that terrorists would prefer to use biological weapons for three reasons:
"First, [biological weapons] agents are far easier to acquire than nuclear weapons and produce the same killing impact as [chemical weapons]. Moreover, on a pound-for-pound basis, [biological weapon] agents are far more potent than any of the most deadly [chemical weapon] agents, which must be 'delivered in massive quantities to inflict lethal concentrations over large areas.'
"Second, the effects of biological weapons on a target population would be extremely hard to counter.
"Third, the insidious nature of [biological weapon] agents--composed as they are of living microorganisms with the capacity to reproduce and mutate--has the potential to psychologically 'unhinge' target populations."
Iran and Syria are reported to be among regimes that have received variations of such deadly biological weapons agents and developed their own domestic programs. Each of these countries also has an extensive medical and pharmaceutical research and development infrastructure within which to produce and conceal its biological weapons programs. Iran and Syria also have shared artillery, ballistic missile and munitions technology with each other and likely with Hezbollah for delivery of such pathogens.
Middle East threat reduction requires a far more aggressive and comprehensive approach to deter the proliferation of biological weapons.
Iran's supreme leader, Ayatollah Ali Khamenei, and his powerful clerical and military regime continue to use deceitful tactics to conceal development of an arsenal of virtually untraceable deadly biological weapons that could result in tens of millions of deaths. They are doing it while Israel and the P5+1 --the five permanent members of the U.N. Security Council plus Germany--are contending with the Islamic republic approaching the "red lines" of nuclear enrichment and weapons development.
The threats from these deadly microbial agents are alarming and real. The unleashing of biowarfare agents against Israel and the United States could bring both countries to their knees. These deadly biological weapons programs in Iran and Syria must be stopped.
Jill Bellamy van Aalst is a biological warfare threat analyst. Clare Lopez is a senior fellow at the Center for Security Policy. Reza Khalili, author of "A Time to Betray" (Threshold, 2010), is a former CIA operative and serves on the Task Force on National and Homeland Security.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||text and context|
|Author:||van Aalst, Jill Bellamy; Lopez, Clare; Khalili, Reza|
|Publication:||Iran Times International (Washington, DC)|
|Date:||Feb 8, 2013|
|Previous Article:||Iran and the US need a middleman--or two.|
|Next Article:||Iran: journalism is being suffocated.|